Chk1 phosphorylates the tumour suppressor Mig-6, regulating the activation of EGF signalling

EMBO Journal

Volumn 31, Issue 10, 2012, Pages 2365-2377

  Liu, Ning ^a,b   Matsumoto, Masaki ^c   Kitagawa, Kyoko ^a   Kotake, Yojiro ^a   Suzuki, Sayuri ^a   Shirasawa, Senji ^d   Nakayama, Keiichi I ^c   Nakanishi, Makoto ^e   Niida, Hiroyuki ^a   Kitagawa, Masatoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c FUKUOKA UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Chk1; EGFR; Mig 6; phosphorylation

Indexed keywords

ALANINE; CHECKPOINT KINASE 1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; SERINE;

AMINO ACID SUBSTITUTION; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DNA DAMAGE; GENE; GENE PRODUCT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; MIG 6 GENE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SUBSTITUTION; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; HUMANS; MASS SPECTROMETRY; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN KINASES; SERINE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84861197351     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2012.88     Document Type: Article

References (42)

1. Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M, Sommergruber W (2004) Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res 64: 844-856 (Pubitemid 38176883)
2. Anastasi S, Baietti MF, Frosi Y, Alema S, Segatto O (2007) The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity. Oncogene 26: 7833-7846 (Pubitemid 350261785)
3. Anastasi S, Fiorentino L, Fiorini M, Fraioli R, Sala G, Castellani L, Alema S, Alimandi M, Segatto O (2003) Feedback inhibition by RALT controls signal output by the ErbB network. Oncogene 22: 4221-4234 (Pubitemid 36876243)
4. Anastasi S, Sala G, Huiping C, Caprini E, Russo G, Iacovelli S, Lucini F, Ingvarsson S, Segatto O (2005) Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin. Oncogene 24: 4540-4548 (Pubitemid 41032617)
5. Chen MS, Ryan CE, Piwnica-Worms H (2003) Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol 23: 7488-7497 (Pubitemid 37271450)
6. Ferby I, Reschke M, Kudlacek O, Knyazev P, Pante G, Amann K, Sommergruber W, Kraut N, Ullrich A, Fässler R, Klein R (2006) Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nat Med 12: 568-573
7. Fiorentino L, Pertica C, Fiorini M, Talora C, Crescenzi M, Castellani L, Alema S, Benedetti P, Segatto O (2000) Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain. Mol Cell Biol 20: 7735-7750
8. Fiorini M, Ballaro C, Sala G, Falcone G, Alema S, Segatto O (2002) Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control. Oncogene 21: 6530-6539 (Pubitemid 35155457)
9. Frangioni JV, Neel BG (1993) Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal Biochem 210: 179-187 (Pubitemid 23147952)
10. Gonzalez FA, Raden DL, Davis RJ (1991) Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J Biol Chem 266: 22159-22163 (Pubitemid 21908629)
11. Guha U, Chaerkady R, Marimuthu A, Patterson AS, Kashyap MK, Harsha HC, Sato M, Bader JS, Lash AE, Minna JD, Pandey A, Varmus HE (2008) Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. Proc Natl Acad Sci USA 105: 14112-14117
12. Hackel PO, Gishizky M, Ullrich A (2001) Mig-6 is a negative regulator of the epidermal growth factor receptor signal. Biol Chem 382: 1649-1662 (Pubitemid 34100596)
13. Jean C, Hernandez-Pigeon H, Blanc A, Charveron M, Laurent G (2007) Epidermal growth factor receptor pathway mitigates UVAinduced G2/M arrest in keratinocyte cells. J Invest Dermatol 127: 2418-2424 (Pubitemid 47619744)
14. Kitagawa M, Higashi H, Jung HK, Suzuki-Takahashi I, Ikeda M, Tamai K, Kato J, Segawa K, Yoshida E, Nishimura S, Taya Y (1996) The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J 15: 7060-7069 (Pubitemid 27023276)
15. Klein S, Levitzki A (2009) Targeting the EGFR and the PKB pathway in cancer. Curr Opin Cell Biol 21: 185-193
16. Lam MH, Rosen JM (2004) Chk1 versus Cdc25: checking one's levels of cellular proliferation. Cell Cycle 3: 1355-1357 (Pubitemid 40310665)
17. Leitner A, Lindner W (2009) Chemical tagging strategies for mass spectrometry-based phospho-proteomics. Methods Mol Biol 527: 229-243
18. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ (2000) Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 14: 1448-1459 (Pubitemid 30421838)
19. Mabuchi R, Sasazuki T, Shirasawa S (2005) Mapping of the critical region of mitogen-inducible gene-6 for NF-kB activation. Oncol Rep 13: 473-476
20. Makkinje A, Quinn DA, Chen A, Cadilla CL, Force T, Bonventre JV, Kyriakis JM (2000) Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress. J Biol Chem 275: 17838-17847 (Pubitemid 30430836)
21. Mailand N, Falck J, Lukas C, Syljuâsen RG, Welcker M, Bartek J, Lukas J (2000) Rapid destruction of human Cdc25A in response to DNA damage. Science 288: 1425-1429 (Pubitemid 30366329)
22. Muslin AJ, Tanner JW, Allen PM, Shaw AS (1996) Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84: 889-897 (Pubitemid 26106858)
23. Niida H, Nakanishi M (2006) DNA damage checkpoints in mammals. Mutagenesis 21: 3-9 (Pubitemid 43288730)
24. Niida H, Tsuge S, Katsuno Y, Konishi A, Takeda N, Nakanishi M (2005) Depletion of Chk1 leads to premature activation of Cdc2- cyclin B and mitotic catastrophe. J Biol Chem 280: 39246-39252 (Pubitemid 41713877)
25. O'Neill T, Giarratani L, Chen P, Iyer L, Lee CH, Bobiak M, Kanai F, Zhou BB, Chung JH, Rathbun GA (2002) Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach. J Biol Chem 277: 16102-16115 (Pubitemid 34967896)
26. Pante G, Thompson J, Lamballe F, Iwata T, Ferby I, Barr FA, Davies AM, Maina F, Klein R (2005) Mitogen-inducible gene 6 is an endogenous inhibitor of HGF/Met-induced cell migration and neurite growth. J Cell Biol 171: 337-348 (Pubitemid 41540025)
27. Puc J, Keniry M, Li HS, Pandita TK, Choudhury AD, Memeo L, Mansukhani M, Murty VV, Gaciong Z, Meek SE, Piwnica-Worms H, Hibshoosh H, Parsons R (2005) Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 7: 193-204 (Pubitemid 40248344)
28. Reschke M, Ferby I, Stepniak E, Seitzer N, Horst D, Wagner EF, Ullrich A (2010) Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma. Hepatology 51: 1383-1390
29. Ruan DT, Warren RS, Moalem J, Chung KW, Griffin AC, Shen W, Duh QY, Nakakura E, Donner DB, Khanafshar E, Weng J, Clark OH, Kebebew E (2008) Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF (V600E) positive papillary thyroid cancers. Surgery 144: 908-913 discussion 913-914
30. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM, Abraham RT (1999) Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 59: 4375-4382 (Pubitemid 29418757)
31. Schmitt E, Boutros R, Froment C, Monsarrat B, Ducommun B, Dozier C (2006) CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage. J Cell Sci 119: 4269-4275 (Pubitemid 44774033)
32. Shimada M, Niida H, Zineldeen DH, Tagami H, Tanaka M, Saito H, Nakanishi M (2008) Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression. Cell 132: 221-232 (Pubitemid 351172429)
33. Tong J, Taylor P, Jovceva E, St-Germain JR, Jin LL, Nikolic A, Gu X, Li ZH, Trudel S, Moran MF (2008) Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. J Proteome Res 7: 1067-1077
34. Tsunoda T, Inokuchi J, Baba I, Okumura K, Naito S, Sasazuki T, Shirasawa S (2002) A novel mechanism of nuclear factor kB activation through the binding between inhibitor of nuclear factor-kBa and the processed NH2-terminal region of Mig-6. Cancer Res 62: 5668-5671 (Pubitemid 35204719)
35. Uto K, Inoue D, Shimuta K, Nakajo N, Sagata N (2004) Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism. EMBO J 23: 3386-3396 (Pubitemid 39209162)
36. Woodgett JR, Gould KL, Hunter T (1986) Substrate specificity of protein kinase C. Use of synthetic peptides corresponding to physiological sites as probes for substrate recognition requirements. Eur J Biochem 161: 177-184 (Pubitemid 17044459)
37. Xiao Z, Xue J, Semizarov D, Sowin TJ, Rosenberg SH, Zhang H (2005) Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics. Int J Cancer 115: 528-538 (Pubitemid 40656709)
38. Xu DZ, Makkinje A, Kyriakis JM (2005) Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function. J Biol Chem 280: 2924-2933 (Pubitemid 40189402)
39. Zhang XW, Pickin KA, Bose R, Jura N, Cole PA, Kuriyan J (2007) Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450: 741-745
40. Zhang YW, Staal B, Su Y, Swiatek P, Zhao P, Cao B, Resau J, Sigler R, Bronson R, Vande Woude GF (2007) Evidence that MIG-6 is a tumour-suppressor gene. Oncogene 26: 269-276 (Pubitemid 46095737)
41. Zhang YW, Vande Woude GF (2007) Mig-6, signal transduction, stress response and cancer. Cell Cycle 6: 507-513 (Pubitemid 46440419)
42. Zhou BB, Elledge SJ (2000) The DNA damage response: putting checkpoints in perspective. Nature 408: 433-439